|
principal investigator :
Mercč Boada
mboada@fundacioace.com
Department:
Center:
Barcelona Alzheimer Treatment and Research Center
Institution:
Fundació ACE. Institut Catalŕ de Neurocičncies Aplicades
Members: 12
Research lines:
Research focused on the study of neuropsychological and clinical phenotypes of Alzheimer's disease (AD) and frontotemporal dementia (FTLD); studies of gene expression in AD, FTLD and DLB, and neuroimaging biomarkers in prodromal AD, as well as independent research to develop new treatments in AD
Areas:
Cognition
Expressió genčtica i biomarcadors
Assaigs clínics de tractaments
Keywords:
Dementia, aging, Alzheimer's disease, mild cognitive impairment, molecular genetics, clinical trials, biomarkers, neuroimaging,behavioural disorders, neuropsychological assessments
Publications:
Lambert, J.-C., et al. (2013). Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nature genetics, 1-9. doi:10.1038/ng.2802
Boada M, et al. “ATP5H/KCTD2 locus is associated with Alzheimer’s disease risk”. Molecular Psychiatry 2013: 2013 July 16 (published online). DOI: 10.1038/mp.2013.86
Hernández I, et al. 2013. Identification of Misdiagnosed Fronto-Temporal Dementia using APOE Genotype and Phenotype-Genotype Correlation Analyses. Curr. Alzheimer Res.
Group Web site
|
